Treatment of Wounds in Elderly Diabetic Patients
The best treatment approach for wounds in elderly diabetic patients centers on sharp debridement combined with basic moisture-retentive dressings and appropriate offloading, while avoiding the vast majority of advanced therapies that lack evidence for improving outcomes. 1, 2
Core Standard of Care
The foundation of diabetic wound management consists of three essential components that must be optimized before considering any adjunctive therapies:
Sharp Debridement
- Perform sharp debridement (using scalpel, scissors, or tissue nippers) to remove necrotic tissue, slough, debris, eschar, and surrounding callus 1, 2
- The frequency should be determined by clinical need rather than a fixed schedule 1, 2
- This is superior to autolytic, biosurgical, hydrosurgical, chemical, enzymatic, laser, or ultrasonic debridement methods 1
- Do NOT use surgical debridement when sharp debridement can be performed outside a sterile environment 1, 3
- Relative contraindications include severe pain or severe ischemia 3
Basic Wound Dressings
- Use dressings that absorb exudate and maintain a moist wound healing environment 1, 2
- Select based on wound characteristics: hydrogels for dry/necrotic wounds, alginates or foams for exudative wounds, films for moistening dry wounds 1
- Do NOT use topical antiseptic or antimicrobial dressings for wound healing purposes (strong recommendation, moderate certainty) 1, 3, 2
- Do NOT use honey, collagen, alginate, phenytoin, or herbal remedy-impregnated dressings (strong recommendations) 1, 3
Offloading
- Use a non-removable knee-high offloading device as first-line treatment for neuropathic plantar forefoot or midfoot ulcers 2
- For patients with limited access to specialized devices, consider felted foam with appropriate footwear 2
- Patients with bony deformities may require extra wide/deep shoes or custom-molded shoes for severe deformities including Charcot foot 2
What NOT to Use (Critical to Avoid)
The 2024 IWGDF guidelines provide strong recommendations against numerous interventions that delay appropriate care:
Strongly Contraindicated Interventions
- Do NOT use physical therapies (electricity, magnetism, ultrasound, shockwaves) 1, 3
- Do NOT use cold atmospheric plasma, ozone, nitric oxide, or CO2 1, 3
- Do NOT use pharmacological agents promoting perfusion/angiogenesis, vitamin/trace element supplements, red cell production stimulants, or protein supplementation 1, 3
- Do NOT use autologous skin grafts 1, 3
- Do NOT use cellular or acellular skin substitute products routinely 1, 3
- Do NOT use growth factor therapy routinely 1, 3
- Do NOT use negative pressure wound therapy for non-surgical diabetic foot ulcers (strong recommendation) 1, 3
Adjunctive Therapies (Only After Standard Care Fails)
Consider these interventions ONLY when best standard care (debridement, dressings, offloading) has been ineffective for at least 2 weeks:
Conditional Recommendations (Moderate Evidence)
- Sucrose-octasulfate impregnated dressing for non-infected, neuro-ischemic ulcers with insufficient improvement after 2+ weeks of optimal standard care 1, 2
- Autologous leucocyte, platelet, and fibrin patch (NOT other platelet therapies) where standard care has failed and resources exist for regular venepuncture 1, 2
Conditional Recommendations (Low Evidence)
- Hyperbaric oxygen therapy for neuro-ischemic or ischemic ulcers where standard care has failed and resources already exist 1, 2
- Topical oxygen therapy where standard care has failed and resources exist 1
- Placental-derived products where standard care has failed 1
- Negative pressure wound therapy ONLY for post-surgical wounds (not for non-surgical ulcers) 1
Additional Management Considerations
Infection Control
- Systemic antibiotics should ONLY be used when clinical signs of infection are present (erythema, warmth, swelling, tenderness, purulent discharge) 1
- Do NOT use topical antimicrobials for uninfected wounds 1, 2
Vascular Assessment
- Ensure adequate arterial perfusion to the wound site, as ischemia is a relative contraindication to aggressive debridement 1, 3
- Consider revascularization when indicated 1
Metabolic Optimization
- Aggressively correct hyperglycemia, as it delays wound healing through osmotic diuresis, decreased oxygenation, and impaired neutrophil function 4
Monitoring
- Reassess treatment if insufficient improvement occurs after 2 weeks 2
- High-risk patients require monitoring every 1-3 months 2
- Educate patients about daily foot inspection, especially critical for those with sensory deficits 2
Common Pitfalls to Avoid
- Failing to provide adequate offloading is the most common error 2
- Overreliance on advanced therapies before optimizing standard care (debridement, dressings, offloading) 3, 2
- Using antimicrobial dressings without evidence of infection 3, 2
- Premature use of negative pressure wound therapy for non-surgical wounds 3
- Neglecting recurrence risk after healing—prescribe therapeutic footwear with demonstrated plantar pressure-relieving effect for healed plantar ulcers 2